Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 28, 2023
Determinants of informal care time, distress, depression, and quality of life in care partners along the trajectory of Alzheimer's diseaseArenda Mank, Ingrid S van Maurik, Judith J M Rijnhart, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2022
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trialAgnetha D Fruijtier, Jetske van der Schaar, Ingrid S van Maurik, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2022
Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second LockdownEls D Bakker, Ingrid S van Maurik, Arenda Mank, et al.
Alzheimer'S Research & Therapy|April 17, 2019
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE projectIngrid S van Maurik, Rosalinde E R Slot, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2018
Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE projectEline A J Willemse, Ingrid S van Maurik, Betty M Tijms, et al.
European Radiology|May 31, 2022
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's diseaseSilvia Ingala, Ingrid S van Maurik, Daniele Altomare, et al.
Alzheimer'S Research & Therapy|October 3, 2025
Usability and feasibility of ADappt: a digital toolkit to support communication on diagnosis and prognosis in memory clinicsHeleen M A Hendriksen, Tanja J de Rijke, Aniek M van Gils, et al.
Alzheimer'S Research & Therapy|December 3, 2025
Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderlyMadison I J Honey, Ingrid S van Maurik, Argonde C van Harten, et al.
Pageof 4